Peer Review History
| Original SubmissionSeptember 17, 2021 |
|---|
|
PONE-D-21-30098Bio-fabrication of stem cell-incorporated corneal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regenerationPLOS ONE Dear Dr. Sawangmake, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Panayiotis Maghsoudlou Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://aje.com/go/plos) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: he authors should check their manuscript for consistency, for instance ml and mL are both used. Also, numbers are written in full and as numbers; please write numbers until twenty in full and higer in numbers. Language remarks: 45: I have been told never to use abbreviations in the abstract of an article. Even more, they are not defined upon their first use in the abstract. 76: corneal grafts 83-84: the use of the ex. Abbreviation is not common. Please use alternatives such as: for example, e.g. etc. (also on line 91) 92: transparency 107: promising: remove 109: “were replenished the knowledge” � change 143: remove a before 2 ml 302: In brief: … � change the structure of the sentence. 345: twice of… use correct English formulation 361: shield instead of shied 415: incorrect use of language 439 decreased instead of deceased 530 Pax6 was similar pattern is no correct English. 645: promote instead of promotes 647: revise sentence 720: gelatin containing RGD 740: therefor … revise sentence 755: arise from… what is meant here? Reviewer #2: Bio-fabrication of stem cell-incorporated corneal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration The authors propose a new technology for bio-engineering corneal tissue using silk fibroin/gelatin films and scaffolds as careers to grow, respectively, limbal stem cells and corneal stromal stem cells. LSC seeded films and CSSC seeded scaffolds were assembled using tissue glue. Canine stem cells were used to prepare artificial corneas aimed at treating dogs with corneal blindness. Abstract. Many abbreviations are used in the abstract (LSC, CSSC..). They should be first shown in full (limbal stem cell…). Otherwise the abstract is difficult to read. The manuscript should be corrected for language by a native English speaker as many sentences are awkward or difficult to understand. “In humans and animals, corneas consist of 5 recognized layers including 3 cellular layers (epithelium, stroma, and endothelium) and 2 acellular layers (Bowman’s layer and Descemet’s membrane).” Descemet’s membrane is not a corneal layer. It is the corneal endothelium basement membrane. “LESCs and CSSCs have been progressed in stem cell properties ex. clonal growth in vitro, extended lifespan, and the ability of differentiation in particular keratocytes.” What does this sentence mean? “Various materials have been used to fabricate three-dimensional (3-D) biocompatible scaffolds such as silk protein.” The main material used as a scaffold is collagen (see Fagerholm, P., Lagali, N.S., Merrett, K. et al., 2010. A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a Phase 1 clinical study. Sci. Transl. Med. Tidu, A., Ghoubay-Benallaoua, D., Teulon, C., et al., 2018. Highly concentrated collagen solutions leading to transparent scaffolds of controlled three-dimensional organizations for corneal epithelial cell colonization. Biomater. Sci…). Preparation of gelatin. The authors should provide the characteristics of the gelatin used in their study (specie, preparation process, chemical characteristics). “Unilateral/Bilateral corneas were obtained from fifteen cadaveric healthy dog eyes” Please provide the spicy. Figure legends are lacking. Fig. 1. Images of immunofluorescence of the various markers used to characterize stem cells would be needed. Although informative, RT-PCR graphs do not allow protein staining intensity and localization to be observed. Fig 1B shows a colony of spindle-shaped fibroblasts that are not features of CSSC. Did the authors obtain spheres when growing CSSC? (see Ghoubay-Benallaoua D, et al. Easy xeno-free and feeder-free method for isolating and growing limbal stromal and epithelial stem cells of the human cornea. PLoS One 2017). 3D colonization of the CSSC seeded scaffolds is an important issue. Fig. 3 does not provide evidence of 3D colonization as SEM is only a surface technique. Please provide cross-sections with the top and bottom surfaces of the scaffold identified. “Cross-sectional figure demonstrated the upper part of cLESCs seeded SF/G corneal film adhered to the lower part of cCSSCs seeded SF/G stromal scaffold, besides the interconnected space was absent.” This sentence is not supported by Fi. 6 which shows a large space between the film and the scaffold (HES). FiG. 6 shows the stromal ultrastructure is quite different from the normal corneal stromal ultrastructure. The obtained ultrastructure is not likely to be associated with a high level of transparency as it is completely disorganized. “By our established technique, the stem cell-incorporated corneal equivalents for canine corneal regeneration were successfully generated.” This sentence is not supported by the data shown. Discussion should mention three major study limitations. First, the normal corneal stromal ultrastructure was not regenerated preventing normal transparency to be reached. Second, the material transparency at various light wavelengths was not assessed. Last no attempt to seed the reconstructed tissue with endothelial cells was made. As a result, the resulting bio-engineered tissue cannot be used for penetrating or endothelial keratoplasty. Reviewer #3: The manuscript titled, "Bio-fabrication of stem cell-incorporated corneal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration" describes silk fibroin and gelatin mixed biomaterials as a scaffold material for canine corneal tissue regeneration. Authors prepared silk fibroin and primary limbal epithelial stem cells and corneal stromal stem cells for this study. Additionally, cLESCs and cCSSCs cultured SF/G scaffolds were cultured for up to 28 days and analysed for corneal cell specific markers. The corneal regeneration study is not so many until now and this manuscript is accountable for the cell proliferation and tissue regeneration trial. However, there are points to be addressed prior to publication. Major points; 1. Discuss about the advantages of gelatin mixing with the silk fibroin. There looks minimal advantage with the addition of gelatin, as it is soluble to water and the gelatin content in the silk fibroin scaffold would be lower than initial mixing ratio. 2. In the title, the expression "Corneal equivalents" is inappropriate because this study does not include corneal endothelium. Corneal endothelium is essential for maintaining transparent cornea by pumping out water and dehydrate corneal stroma. 3. Add discussion about the corneal endothelium for corneal equivalent biofabrication in the discussion part. 4. Figure 7. There looks negligible cell number and collagen amount change during day 14 and day 28. It is recommended to add images of culture day 1 and add quantitative collagen amount data for clear collgen type 1 change with cell culture period. 5. line 457 There are only the mechanical properties of the scaffolds. Recommended to add data for canine corneal tissue mechanical properties. Further, add discussion about the mechanical property data of the scaffolds with the native corneal tissues. 6. Overall, quantitative result data were not written or included in the results parts. The numbers and statistical significance should be included in the manuscript. Minor points; 1. Use subscript for W0, Wt. 2. Use symbol instead of alphabet "X" in the equation. 3. Add scale bars in the figure legends. 4. line 127 molar concentration is missing. : 9.3M LiBr solution 5. line 154 Detailed description is needed how the air interphase area of scaffolds was removed. 6. line 155 Please describe in detail how the scaffold was made into 1 mm thickness(include tool, procedure and so on). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Bert Van den Bogerd Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Bio-fabrication of stem-cell-incorporated corneal epithelial and stromal equivalents from silk fibroin and gelatine-based biomaterial for canine corneal regeneration PONE-D-21-30098R1 Dear Dr. Sawangmake, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Panayiotis Maghsoudlou Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-30098R1 Bio-fabrication of stem-cell-incorporated corneal epithelial and stromal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration Dear Dr. Sawangmake: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Panayiotis Maghsoudlou Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .